HOME >> MEDICINE >> NEWS
Queensland to be hub of Australasian kidney network

The growing problem of kidney disease will be tackled head on with the formation of a new Queensland-based research network.

To be co-ordinated through The University of Queensland's Queensland Clinical Trials Centre at the Princess Alexandra Hospital, the $1.29 million Australasian Kidney Trials Network (AKTN) will aim to improve the health and quality of life of people suffering from kidney disease.

Associate Professor Carmel Hawley, Chair of the Brisbane-based Operations Secretariat of the Network, said the AKTN would draw together leading researchers in kidney disease from around Australia and New Zealand.

"Kidney disease is one biggest health issues facing Australia at the moment along with heart disease and diabetes," Dr Hawley said.

"It affect one in seven Australian adults and there are 1.7 million people with moderate to severe chronic kidney disease.

"This Network will be focused on new and innovative clinical research to provide better treatments and outcomes for patients.

"We already have 10 trials submitted to the network researching varying treatments for chronic kidney diseases such as dialysis and transplants."

Dr Hawley said kidney disease affected one in seven Australian adults, with 1.7 million people with moderate to severe chronic kidney disease.

Other UQ researchers involved in the Network include Elaine Beller from the School of Population Health and Professors David Johnson and Wendy Hoy from the School of Medicine.

Dr Hawley said this focus on treatment and prevention trials was unique in Australia and would be a new approach to the varying renal diseases.

"The Network will be at the forefront of knowledge creation and address complex economic, technological and social needs relating to the patient care and the translation of research into clinical practice," she said.

The AKTN is the recipient of an National Health and Medical Research Council
'"/>

Contact: Associate Professor Carmel Hawley
61-732-405-080
Research Australia
14-Jul-2005


Page: 1 2

Related medicine news :

1. University of Queensland and Harvard Medical International to nourish the health workforce
2. 1 of 2 pediatric kidney disease research centers in world established
3. Indiana University Imaging Center receives $6M grant for kidney research
4. Obesity linked to hyperparathyroidism in chronic kidney disease
5. Study shows radiofrequency ablation highly effective in treating kidney tumors
6. Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders
7. Quality versus quantity -- transforming kidney transplant policy
8. ACE inhibitors help preserve kidney function in IgA nephropathy
9. Treatment of kidney condition requires an individualized approach
10. Study evaluates why blacks do not successfully donate kidneys
11. Cause of gender differences in blood pressure, kidney damage under study

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Queensland hub Australasian kidney network

(Date:8/27/2015)... ... 2015 , ... In mid-May, Logistics Trust, Inc. (“Logistics Trust”) ... of its Doobster platform, a HIPAA-compliant mobile application that allows medical marijuana patients ... and tablets. Well, Doobster, “The App That Delivers!” is here! You ...
(Date:8/27/2015)... ... ... The Naderi Center is proud to announce that its own Dr. Jessica ... fat. The first and only Food and Drug Administration (FDA) approved treatment for ... only Board Certified surgeon in the D.C., Maryland, Virginia area to offer this innovative, ...
(Date:8/27/2015)... ... August 27, 2015 , ... Zensah®, ... Glushko, professional Tennis player for Israel in the Women’s Tennis Association (WTA). Glushko ... her training and recovery. , With a focus on technology and comfort, Zensah® ...
(Date:8/27/2015)... OKLAHOMA CITY, OK (PRWEB) , ... August 27, ... ... Partners (“GPP”) I, LP portfolio company and leading biopharmaceutical contract development manufacturing company ... acquired by Hepalink USA Inc. (“Hepalink”) for $205.68M in cash. , ...
(Date:8/27/2015)... , ... August 27, 2015 , ... Susan Harris ... procedure to relieve vaginal discomfort due to pre- and post-menopause, chemotherapy, and child birth. ... CO2 laser, which delivers controlled energy to the vaginal tissue, revitalizing cells so they ...
Breaking Medicine News(10 mins):Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 3Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 4Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 2Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 3
(Date:8/27/2015)... , Aug. 27, 2015 Major pharmaceutical and ... at a legal conference in Philadelphia ... emerging issues, Tom Hagy of HB Litigation Conferences ... event, visit HB,s website at http://litigationconferences.com/?p=31886 ... Segal McCambridge Singer & Mahoney and Michelle Hart Yeary ...
(Date:8/27/2015)... 27, 2015 Itamar Medical Ltd. ... investment in public equity (PIPE) deal, in which Viola ... Itamar Medical.   Through this deal, Viola ... Medical and will work closely with the company,s management ... to the investment agreement, Itamar Medical will issue shares ...
(Date:8/27/2015)... , August 27, 2015 ... Persistence Market Research titled "Global Market Study on ... Growth by 2021", the urinary catheters market is expected to ... of 2015. It is anticipated to expand at ... reach US$1,755.0 Mn by 2021. View ...
Breaking Medicine Technology:Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 2Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 4Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 5Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 3Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 4
Cached News: